DOI: 10.4244/EIJV10I1AA22

Quadricuspid aortic valve stenosis which caused multi-organ failure and was treated by transcatheter aortic valve implantation after balloon aortovalvuloplasty as a bridge therapy

Cheol Woong Yu*, MD, PhD; Hyun Jong Lee, MD

Quadricuspid aortic valve (QAV) is a rare congenital malformation and is often associated with other congenital heart anomalies1. QAV is frequently associated with regurgitation but stenosis is very unusual2-4. An 80-year-old male patient presented with multi-organ failure. Echocardiography showed a severe left ventricular systolic dysfunction with moderate mitral regurgitation and severe aortic stenosis. To save the patient, we performed balloon aortovalvuloplasty as a bridge therapy to definite aortic valve replacement, in order to minimise the procedure. Thereafter, he fully recovered from the multi-organ failure. For pre-TAVI assessment, computed tomographic angiography (CTA) (Figure 1A, Figure 1B) and transoesophageal echocardiography (Figure 1C, Moving image 1) were performed. We found the stenosed QAV without other congenital heart anomalies. The patient underwent implantation of a 26 mm Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, CA, USA) via a transfemoral approach with the guidance of Heart Navigator System (Heart Navigator 1.0.0; Philips Healthcare, Best, The Netherlands) for optimal valve positioning (Moving image 2). The CTA confirmed the proper positioning of the valve (Online Figure 1).

Figure 1. Multi-planar reconstructed computed tomographic angiographic images (A, B) and midoesophageal short-axis view (C) demonstrating quadricuspid aortic valve with thickened leaflet margin, 4 separate leaflets, and moderate calcifications.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Moving image 1. Midoesophageal short-axis view of transoesophageal echocardiography showed a quadricuspid aortic valve with four equal-sized cusps, a central coaptation defect, central aortic regurgitation and limited motion of aortic valve leaflets.

Moving image 2. Transcatheter aortic valve implantation was performed by guidance of Heart Navigator System, transoesophageal echocardiogram and aortogram for optimal valve positioning.

Online Figure 1. Postoperative follow-up computed tomographic angiography to ensure proper positioning of the valve: short-axis view (A) and sagittal view (B).

Volume 10 Number 1
May 20, 2014
Volume 10 Number 1
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-20-00076 Apr 3, 2020
Transcatheter aortic valve implantation in unicuspid aortic valve stenosis
Chopra A et al
free

Research correspondence

10.4244/EIJ-D-22-00740 Apr 24, 2023
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis
Vanhaverbeke M et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00690 Aug 28, 2020
Transcatheter aortic valve implantation after transcatheter mitral valve implantation
Kuhn E et al
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.13

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved